News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Woiwode Thomas
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/26/2023 |
4
| Woiwode Thomas (10% Owner) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 24,000 options to buy
@ $1, valued at
$24k
|
|
| 06/27/2022 |
4
| Woiwode Thomas (Director) has filed a Form 4 on Aligos Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $1.34, valued at
$20.1k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Woiwode Thomas (10% Owner) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 24,000 options to buy
@ $1.76, valued at
$42.2k
|
|
| 05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/27/2021 |
4
| Woiwode Thomas (Director) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Disposed of 444,744 shares
@ $0
Acquired 6,668 shares
@ $0
Disposed of 6,668 shares
@ $0
Acquired 6,612 shares
@ $0
Disposed of 6,612 shares
@ $0
Acquired 128 shares
@ $0 |
|
| 07/06/2021 |
4
| Woiwode Thomas (10% Owner) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 6,635 options to buy
@ $11.07, valued at
$73.4k
|
|
| 06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Woiwode Thomas (10% Owner) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 16,918 options to buy
@ $13.83, valued at
$234k
|
|
| 05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2020 |
4
| Woiwode Thomas (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Acquired 12,783 shares
@ $0 |
|
| 10/20/2020 |
4
| Woiwode Thomas (Director) has filed a Form 4 on Aligos Therapeutics, Inc.|
Txns:
| Converted 2,145,991 shares
@ $0
Converted 198,839 shares
@ $0
Converted 85,065 shares
@ $0
Converted 463,959 shares
@ $0
Converted 198,485 shares
@ $0
Bought 200,000 shares
@ $15, valued at
$3M
Converted 2,145,991 preferred shares
@ $0
Converted 198,839 preferred shares
@ $0
Converted 463,959 preferred shares
@ $0
Converted 85,065 preferred shares
@ $0
Converted 198,485 preferred shares
@ $0 |
|
| 06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2020 |
4
| Woiwode Thomas (10% Owner) has filed a Form 4 on Gritstone Oncology, Inc.|
Txns:
| Granted 12,500 options to buy
@ $6.66, valued at
$83.3k
|
|
| 03/03/2020 |
4
| Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Converted 2,977,242 shares
@ $0
Converted 1,049,175 shares
@ $0
Converted 708,352 shares
@ $0
Bought 225,000 shares
@ $18, valued at
$4.1M
Converted 2,977,242 preferred shares
@ $0
Converted 1,049,175 preferred shares
@ $0
Converted 708,352 preferred shares
@ $0 |
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/20/2019 |
4
| Woiwode Thomas (10% Owner) has filed a Form 4 on Gritstone Oncology, Inc.|
Txns:
| Granted 8,570 options to buy
@ $10.86, valued at
$93.1k
|
|
| 10/02/2018 |
4
| Woiwode Thomas (10% Owner) has filed a Form 4 on Gritstone Oncology, Inc.|
Txns:
| Converted 3,102,929 shares
@ $0
Converted 2,173,909 convertible preferred
@ $0
Converted 929,020 convertible preferred
@ $0 |
|
| 06/15/2018 |
4
| Woiwode Thomas (Director) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 30,000 options to buy
@ $59.31, valued at
$1.8M
|
|
| 06/15/2018 |
4
| Woiwode Thomas (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 35,000 options to buy
@ $6.25, valued at
$218.8k
|
|
| 05/17/2018 |
4
| Woiwode Thomas (Director) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Sold 43,000 shares
@ $57.97, valued at
$2.5M
Sold 1,000 shares
@ $58.73, valued at
$58.7k
|
|
| 05/09/2018 |
4
| Woiwode Thomas (Director) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Sold 97,550 shares
@ $50.31, valued at
$4.9M
Sold 2,862 shares
@ $50.31, valued at
$144k
Sold 3,172 shares
@ $50.31, valued at
$159.6k
Sold 7,424 shares
@ $50.31, valued at
$373.5k
Sold 7,645 shares
@ $51.26, valued at
$391.9k
Sold 225 shares
@ $51.26, valued at
$11.5k
Sold 249 shares
@ $51.26, valued at
$12.8k
Sold 582 shares
@ $51.26, valued at
$29.8k
Sold 1,653 shares
@ $51.45, valued at
$85k
|
|
| 05/02/2018 |
4
| Woiwode Thomas (Director) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Sold 26,860 shares
@ $50.29, valued at
$1.4M
Sold 788 shares
@ $50.29, valued at
$39.6k
Sold 874 shares
@ $50.26, valued at
$43.9k
Sold 2,044 shares
@ $50.29, valued at
$102.8k
|
|
| 04/30/2018 |
4
| Woiwode Thomas (Director) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Sold 185,075 shares
@ $50.11, valued at
$9.3M
Sold 5,430 shares
@ $50.12, valued at
$272.2k
Sold 6,019 shares
@ $50.12, valued at
$301.7k
Sold 14,086 shares
@ $50.11, valued at
$705.8k
Sold 10,236 shares
@ $50.02, valued at
$512k
Sold 300 shares
@ $50.08, valued at
$15k
Sold 333 shares
@ $50.01, valued at
$16.7k
Sold 779 shares
@ $50.03, valued at
$39k
|
|
| 04/26/2018 |
4
| Woiwode Thomas (Director) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Sold 20,071 shares
@ $51, valued at
$1M
Sold 589 shares
@ $50.6, valued at
$29.8k
Sold 653 shares
@ $51, valued at
$33.3k
Sold 1,528 shares
@ $51, valued at
$77.9k
|
|
| 04/24/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/27/2017 |
4
| Woiwode Thomas (Director) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Sold 3,059 shares
@ $20.2911, valued at
$62.1k
|
|
| 11/28/2017 |
4
| Woiwode Thomas (Director) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Sold 1,700 shares
@ $20.2105, valued at
$34.4k
Sold 200 shares
@ $20.24, valued at
$4k
|
|
|
|
|